Drug intelligence / Profile preview

UrinStopper Patch

Development stage: Unknown
Lead developer: American Oriental Bioengineering
Modality: Transdermal Patches → Device-based Delivery → Drug Delivery Systems
Administration: Topical

Overview

**UrinStopper Patch** was a proprietary topical patch product associated with American Oriental Bioengineering and marketed for urinary symptoms including bedwetting, frequent urination, and urinary incontinence. Contemporary reporting described package claims that the patch used purported \"radioactive photons\" to warm acupuncture points; however, no established active ingredient, pharmacologically validated mechanism, regulatory approval, or clinical-development evidence for the exact product was identified. It should not be confused with oxybutynin transdermal patches or other regulated treatments for overactive bladder.

Brand names: UrinStopperUrinStopper Patch

Beyond the preview

Go deeper on UrinStopper Patch.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on UrinStopper Patch.

Explore the full profile